Skip to main content

Table 1 : Implementation lead project log template

From: The health and economic impact of implementation strategies for improving detection of hereditary cancer patients—protocol for an in-depth cost-effectiveness evaluation with microsimulation modelling

Implementation Lead Task

(IL task provided by CCNSW)

Scheduled

Actual

Approach to Achieving Task

(i.e. method of contact, number of staff approached)

Time Spent (mins)

Implementation Lead Reflection

(i.e. barriers and facilitators, delays/setbacks, strategies used to address issues)

Outcome

Begin

[date]

End

[date]

Begin

[date]

End

[date]

Example:

Recruit an implementation team of 8-12 health professionals involved in the LS pathway

01/08/18

14/08/18

01/08/18

18/08/18

01/08/18: Hospital Principal Investigator emailed invitation letter to 28 staff members involved in LS pathway. 12 expressions of interest received.

30

Poor attendance at initial Study Brief meeting. Second meeting held, offered to meet with staff individually if unable to attend group study brief meetings.

Implementation Team successfully formed, consisting of 8 health professionals:

     

02/08/18: Emailed interested staff members (n=12) invitation to attend study brief meeting. 8 confirmed attendance.

30

At study brief meeting, staff overall positive but raised concerns about time taken to attend meetings/focus groups held as part of LS implementation approach. Concerned thqt managers would not support. Advised that study has been granted executive approval, offered to arrange meeting with managers to discuss time/resources required for involvement as implementation team member

surgeons=2, oncologist=1, pathologists=2,

     

09/08/18: Held study brief meeting, 6 attended (2x surgeons, 1x medical oncologist, 1x pathologist, 1x genetic counsellor, 1x nurse coordinator). Info packs provided.

90

Deadline for return of consent forms extended as second study brief meeting was required.

clinical nurse coordinator=1

     

10/08/18: Non-attendees (n=6) invited to additional study brief meeting

20

 

genetic counsellor=1, oncology registrar=1

     

12/08/18: Second study brief meeting held, 4 attendees. Info packs provided (1x medical oncologist, 1x surgeon, 1x oncology registrar, 1x nurse)

90

  
     

14/08/18: 5 participation consent forms received. Sent email reminder to remaining staff (n=7). Deadline extended to 18/08/18 – 3 additional consent forms returned.

20